Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.45 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28330086 | 0.98 | LMNA (0.53) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL76327 | 0.98 | LMNA (0.53) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| Sulfur Dioxide SCHEMBL28176580 | 0.94 | LMNA (0.50) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| SCHEMBL460030 | 0.93 | ALDH1A1 (0.49) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| Sulfuric Acid SCHEMBL5004844 | 0.93 | ALDH1A1 (0.49) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL8015558 | 0.91 | MEN1 (0.48) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| Nitric Acid SCHEMBL27965091 | 0.89 | ALDH1A1 (0.47) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| SCHEMBL28161510 | 0.89 | ALDH1A1 (0.47) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| Cadaverine Tartrate SCHEMBL28296884 | 0.89 | MAPT (0.47) | LMNAALDH1A1RAB9AMAPTMEN1 | |
| SCHEMBL11743349 | 0.89 | POLB (0.47) | LMNAALDH1A1RAB9AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 915 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120699943-B | Penicillin acylase for synthesizing beta-lactam antibiotics | 浙江师范大学行知学院 | 2026-05-15 | — | — | CN | claimed |
| CN-119932000-A | Penicillin G acylase AxPGA mutant, expression plasmid, genetically engineered bacterium and application | 浙江昂利康制药股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119409631-A | 2,2 '-Biquinoline-4, 4' -dicarboxylic acid amino acid derivative, and preparation method and application thereof | 武汉大学人民医院（湖北省人民医院） | 2025-02-11 | — | — | CN | claimed |
| CN-119020335-A | Penicillin acylase mutant and application thereof | 浙江师范大学行知学院 | 2024-11-26 | — | — | CN | claimed |
| CN-118151490-B | Photosensitive resin composition, photosensitive dry film and application thereof | 湖南初源新材料股份有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | claimed |
| CN-118185913-A | Paracoccus-derived amidase and application of mutant thereof | 河北科技大学 | 2024-06-14 | — | — | CN | claimed |
| CN-118151490-A | Photosensitive resin composition, photosensitive dry film and application thereof | 湖南初源新材料股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| US-20240027442-A1 | TEST REAGENT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE NEGATIVES | DENKA COMPANY LIMITED (JP) | 2024-01-25 | — | — | US | claimed |
| US-20240011978-A1 | TEST KIT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE POSITIVES | DENKA COMPANY LIMITED (JP) | 2024-01-11 | — | — | US | claimed |
| WO-2000004024-A1 | ANTIPARASITIC ARTEMISININ DERIVATIVES (ENDOPEROXIDES) | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-27 | — | — | WO | claimed |
| EP-0960945-A2 | Enzymatic process for producing beta-lactam antibiotics involving product recovery at pH 1 in the presence of immobilized penicillin amidase | Unifar Kimya Sanayii ve Ticaret A.S (TR) | 1999-12-01 | — | — | EP | claimed |
| US-5801011-A | Process for preparing cephalosporins with penicillin acylase without pH control | ELI LILLY AND COMPANY (US) | 1998-09-01 | — | — | US | claimed |
| US-5736518-A | Peptide compounds of (L) amino acids and ring molecules, and therapeutical applications thereof | POLIFARMA S.P.A. (IT) | 1998-04-07 | — | — | US | claimed |
| EP-0567323-A2 | Improved process for preparing cephalosporins | ELI LILLY AND COMPANY (US) | 1993-10-27 | — | — | EP | claimed |
| EP-0085023-A1 | Process for the separation of enantiomers by partition between liquid phases | CIBA-GEIGY AG (CH) | 1983-08-03 | — | — | EP | claimed |
| US-4322548-A | COMPRISING CONTACTING WITH A PHENYLGLYCINE ESTER | KAY FRIES, INC. (US) | 1982-03-30 | — | — | US | claimed |
| EP-0000932-B1 | PRODUCTION OF N-ACYL-THIENAMYCINS | MERCK & CO. INC. (US) | 1981-10-21 | — | — | EP | claimed |
| EP-0000932-A1 | Production of N-acyl-thienamycins | MERCK & CO. INC. (US) | 1979-03-07 | — | — | EP | claimed |
| US-4135978-A | PRODUCTION OF N-ACYL-THIENAMYCINS | MERCK & CO., INC. (US) | 1979-01-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240027442-A1 | TEST REAGENT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE NEGATIVES | SHBG, CD14, SARS1 | LMNA 3181/4885ALDH1A1 4733/4885RAB9A 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.